Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
One million people who never regularly smoked now vape in England
The number of adults vaping in England who have never regularly smoked has increased sharply…
Epigenetic hallmarks that define cancer
Cancer mortality has just surpassed cardiovascular disease for the first time and one in two…
Experimental blood test improves early detection of pancreatic cancer
An experimental blood test detects early-stage pancreatic cancer more effectively than other available tests, reports…
Antibody targets tumour-promoting molecules deep within cancer cells
- Lung cancer outcomes significantly improved with immunotherapy-based treatment given before and after surgery
- Lung cancer cells can thrive in the brain by recruiting astrocytes for protection
- Amivantamab plus chemo with or without lazertinib reduced risk of disease progression or death for EGFR-mutated NSCLC
Relying only on vaccination in NSW from December 1 isn’t enough – here’s what we need for sustained freedom
C Raina MacIntyre, UNSW; Anne Kavanagh, The University of Melbourne; Eva Segelov, Monash University, and Lisa Jackson Pulver, University of…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.